CN Patent
CN101723891A — 通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法
Assigned to Vertex Pharmaceuticals Inc · Expires 2010-06-09 · 16y expired
What this patent protects
本发明涉及一种通过使N-芳基氨基甲酸酯与卤代杂芳基反应制备N-杂芳基-N-芳基胺的方法和类似方法,涉及下列式(A)或式(B)的化合物,其中每个X 1 、X 2 、X 3 和X 4 独立地选自氟或氯;R是H或甲基。
USPTO Abstract
本发明涉及一种通过使N-芳基氨基甲酸酯与卤代杂芳基反应制备N-杂芳基-N-芳基胺的方法和类似方法,涉及下列式(A)或式(B)的化合物,其中每个X 1 、X 2 、X 3 和X 4 独立地选自氟或氯;R是H或甲基。
Drugs covered by this patent
- Kalydeco (IVACAFTOR) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.